Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
Lu-Hong XuYin WangZhi-Yuan ChenJian-Pei FangPublished in: Journal of cancer research and clinical oncology (2020)
The presence of MS at diagnosis of pediatric AML is associated with poor clinical outcomes, particularly when associated with KMT2A rearrangements. Moreover, pediatric patients with AML and MS may not benefit from SCT.